2021 Biosimilar Approval and Litigation Update
By EsqSocial Corporation 01/02/21
The last two years saw the launch of several biosimilars. Looking ahead to 2021, several others may be on the horizon. In 2019-2020, the FDA approved thirteen biosimilars directed to seven reference products. Eight of the approved biosimilars have launched, while five are either embroiled in litigation or awaiting agreed-upon launch dates....
By: Patterson Belknap Webb & Tyler LLP